In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs) affects immune response to antigens. Therefore, post-vaccination serological assessments are needed to evaluate the effect of the vaccine on SARS-CoV-2 antibody response.
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
Sormani, Maria Pia;Inglese, Matilde;Schiavetti, Irene;Carmisciano, Luca;Laroni, Alice;Lapucci, Caterina;Serrati, Carlo;Gandoglia, Ilaria;Tassinari, Tiziana;Brichetto, Giampaolo;Mannironi, Antonio;Salvetti, Marco;Uccelli, Antonio
2021-01-01
Abstract
In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs) affects immune response to antigens. Therefore, post-vaccination serological assessments are needed to evaluate the effect of the vaccine on SARS-CoV-2 antibody response.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
